Key Highlights
- Net loss per share was USD 1.49, against estimated Earnings of USD 0.15.
- Total revenues were negative USD 25.29 million, from negative USD 2.76 million.
- Net loss widened to USD 39.37 million from USD 17.91 million.
- Cash was USD 7.48 million at September 30, 2026.
Beneficient (NASDAQ:BENF) reported negative total revenues of USD 25.29 million for the second quarter of fiscal 2027, the quarter ended September 30, 2026, compared with negative USD 2.76 million a year earlier. Net loss per Class A and Class B common share was USD 1.49, compared with USD 3.00, while the estimate called for earnings of USD 0.15 per share.
The net loss was USD 39.37 million, compared with USD 17.91 million, and the portion attributable to Beneficient common shareholders was USD 22.06 million, compared with USD 3.63 million. Per-share figures reflect the 1-for-8 Reverse Stock Split effected on December 15, 2025.
What Pulled Revenue Below Zero
Investment loss, net, was USD 13.83 million, compared with USD 3.16 million, and the loss on financial instruments, net, was USD 11.55 million, compared with a gain of USD 211 thousand. Interest and Dividend income was USD 10 thousand, and trust services and administration revenues were USD 85 thousand, compared with USD 178 thousand.
Expenses and Pre-Tax Loss
Employee compensation and benefits expense was USD 2.79 million, compared with USD 2.43 million, and interest expense was USD 4.71 million, compared with USD 4.90 million. Professional services expense, net, fell to USD 3.49 million from USD 5.33 million, other expenses to USD 1.59 million from USD 2.44 million, and the loss on Impairment of Goodwill was USD 1.48 million.
Total operating expenses were USD 14.06 million, compared with USD 15.10 million. The loss before income taxes was USD 39.35 million, compared with USD 17.86 million, and income tax expense was USD 22 thousand, compared with USD 43 thousand.
Six Months to September 30
For the six months ended September 30, 2026, total revenues were negative USD 13.12 million, compared with negative USD 15.39 million. Total operating expenses fell to USD 26.60 million from USD 95.13 million, a prior-year figure that included an accrual of USD 62.83 million for a loss contingency tied to an arbitration award.
The net loss was USD 39.75 million, compared with USD 110.56 million, and the net loss attributable to Beneficient common shareholders was USD 28.84 million, compared with USD 68.71 million. Net loss per common share was USD 1.97, compared with USD 58.68. Net cash used in Operating Activities was USD 14.16 million, compared with USD 25.36 million.
Cash and Going Concern Doubt
Cash and cash equivalents were USD 7.48 million at September 30, 2026, compared with USD 2.54 million at March 31, 2026. Total Assets were USD 227.28 million, compared with USD 238.77 million, and total liabilities were USD 353.81 million, compared with USD 337.53 million.
The filing discloses substantial doubt about whether the company can continue as a going concern. Reasons given include an inability at present to raise enough capital, repeated operating losses, negative operating cash flows, existing events of default on related party debts, delays in carrying out business plans and the Texas Court of Appeals' confirmation of an earlier Equity arbitration award.



_11_17_2026_17_12_19_725518.jpg)


Please wait processing your request...